Infinity | Jotup

Infinity Group acquires RedkiteCRM to drive digitisation in the pressured social housing sector

Retrieved on:

Wednesday, October 4, 2023

Infinity Group, Housing, Internet of things, Market, Microsoft, Accounting, Microsoft Power Platform, First officer (aviation), Microsoft Dynamics 365 Business Central, Acquisition, Infinity, CRM, Growth, Microsoft Dynamics 365, Video game

LONDON, Oct. 4, 2023 /PRNewswire/ -- Infinity Group, a leading Microsoft-focused cloud services, security and business applications partner in the UK, today announced it has acquired RedkiteCRM, one of the few Microsoft-focused Housing Management System providers serving the social housing sector.

Key Points:

LONDON, Oct. 4, 2023 /PRNewswire/ -- Infinity Group, a leading Microsoft-focused cloud services, security and business applications partner in the UK, today announced it has acquired RedkiteCRM, one of the few Microsoft-focused Housing Management System providers serving the social housing sector.
RedkiteCRM provides deep industry expertise and dedicated IP catering to the unique challenges faced by housing associations managing tenant communications and operations.
The acquisition sees Infinity Group grow to 150 full-time employees while expanding its customer base and capabilities to deliver hyper-focused solutions to the social housing sector.
Andy McCormick, Director of Housing, RedkiteCRM: "Joining Infinity Group is a strategic move that will combine our expertise and tailored approach with their scale, delivering on our shared vision for the social housing sector.

ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages Infinity Pharmaceuticals, Inc. Investors to Secure Counsel Before Important October 16 Deadline in Securities Class Action – INFI

Retrieved on:

Tuesday, October 3, 2023

Titan, Partnership, Class, Advertising, Infinity, Court, I-Space (Chinese company), Breast cancer, Insurance, Tobacco

WHAT TO DO NEXT: To join the Infinity class action, go to https://rosenlegal.com/submit-form/?case_id=18465 or call Phillip Kim, Esq.

Key Points:

WHAT TO DO NEXT: To join the Infinity class action, go to https://rosenlegal.com/submit-form/?case_id=18465 or call Phillip Kim, Esq.
The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company.
1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Infinity Pharmaceuticals, Inc. - INFI

Retrieved on:

Tuesday, October 3, 2023

LLP, Head, Mergers and acquisitions, Infinity, Pomerantz, News, Breast cancer, Pharmaceutical industry, Cryptocurrency, Webcast

NEW YORK, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Infinity Pharmaceuticals, Inc. (“Infinity” or the “Company”) (NASDAQ: INFI).

Key Points:

NEW YORK, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Infinity Pharmaceuticals, Inc. (“Infinity” or the “Company”) (NASDAQ: INFI).
The investigation concerns whether Infinity and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
Then, on July 24, 2023, Infinity announced that it was terminating the Merger after failing to obtain stockholder approval.
Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

DEADLINE ALERT for KEY, LYV, APLD, and INFI: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Retrieved on:

Tuesday, October 3, 2023

Cloud, NII, Law, Live Nation Entertainment, KeyBank, Suite, Investment, Infinity, Applied Digital Data Systems, Defendant, Digital, Breast cancer, Security (finance)

LOS ANGELES, Oct. 03, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.

Key Points:

LOS ANGELES, Oct. 03, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.
Investors suffering losses on their investments are encouraged to contact The Law Offices of Frank R. Cruz to discuss their legal rights in these class actions at 310-914-5007 or by email to [email protected] .
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
The Law Offices of Frank R. Cruz, Los Angeles

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Applied Digital, Infinity, and Shift4 and Encourages Investors to Contact the Firm

Retrieved on:

Tuesday, October 3, 2023

Cloud, Workforce, P.C, Bank statement, Head, Shift4, Acquisition, Infinity, Applied Digital Data Systems, Maximization, Hand, NYSE, Breast cancer, Audit, Pharmaceutical industry

Stockholders have until the deadlines below to petition the court to serve as lead plaintiff.

Key Points:

Stockholders have until the deadlines below to petition the court to serve as lead plaintiff.
Throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operations, and compliance policies.
Results were initially so promising that partners were being sought (and prospective partners were interested) to bring eganelisib to the next stage.
For more information on the Shift4 class action go to: https://bespc.com/cases/FOUR

Lead Plaintiff Deadline Approaching: Infinity Pharmaceuticals, Inc. Investors Should Contact Robbins LLP for Information About the Infinity Pharmaceuticals, Inc. Class Action

Retrieved on:

Friday, September 29, 2023

Workforce, LLP, Cancer, Head, Person, Complaint, SAN, Maximization, MEI, News, Breast cancer, Security (finance), Pharmaceutical industry, Inc., Infinity

For more information, submit a form , email Aaron Dumas, Jr., or give us a call at (800) 350-6003.

Key Points:

For more information, submit a form , email Aaron Dumas, Jr., or give us a call at (800) 350-6003.
On this news, the price of Infinity's stock fell from $0.55 on February 23, 2023, to $0.28 on February 23, 2023.
On July 24, 2023, Infinity announced it was terminating the merger because MEI did not obtain stockholder approval for the merger.
A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Infinity Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – INFI

Retrieved on:

Thursday, September 28, 2023

Titan, Partnership, Class, Advertising, Infinity, Court, I-Space (Chinese company), Breast cancer, Insurance, Tobacco

WHAT TO DO NEXT: To join the Infinity class action, go to https://rosenlegal.com/submit-form/?case_id=18465 or call Phillip Kim, Esq.

Key Points:

WHAT TO DO NEXT: To join the Infinity class action, go to https://rosenlegal.com/submit-form/?case_id=18465 or call Phillip Kim, Esq.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles.
The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Live Nation, Applied Digital, and Infinity and Encourages Investors to Contact the Firm

Retrieved on:

Thursday, September 28, 2023

For more information on the Live Nation class action go to: https://bespc.com/cases/LYV

Key Points:

For more information on the Live Nation class action go to: https://bespc.com/cases/LYV
Throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operations, and compliance policies.
On July 24, 2023, Infinity announced that the merger had been terminated, because shareholders of the merging company voted against it.
The next day, on July 25, 2023, Infinity announced a “Value Preservation and Maximization Plan”, whereby it was, among other things, terminating 78% of its workforce.
For more information on the Infinity class action go to: https://bespc.com/cases/INFI

KeyCorp, Live Nation, Applied Digital, and Infinity Pharmaceuticals Class Action Update: Johnson Fistel Alerts Shareholders of Ongoing Legal Proceedings

Retrieved on:

Wednesday, September 27, 2023

Cloud, Borrowing statute, TNBC, Learning, Action Replay, NII, Head, Key, Live Nation Entertainment, Complaint, Infinity, Applied Digital Data Systems, MEI, Breast cancer, Sales, Webcast

Throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operations, and compliance policies.

Key Points:

Throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operations, and compliance policies.
On July 24, 2023, Infinity announced that it was terminating the merger, because MEI did not obtain stockholder approval for the merger.
On July 24, 2023, Infinity announced that it was terminating the merger, because MEI did not obtain stockholder approval for the merger.
An investor's ability to share any potential future recovery of the class action lawsuit is not dependent upon serving as lead plaintiff.

CellFE secures $22 million in Series A financing to advance microfluidics-based cellular engineering platform

Retrieved on:

Wednesday, September 27, 2023

Therapy, Overalls, Research, Patient, Alla, Khosla Ventures, Infinity, Annual general meeting, Growth, Merck Group, Pharmaceutical industry, Vaccine

Therapy developers are forging partnerships with technology providers, such as CellFE, to advance innovative solutions, with the aim to benefit patients seeking better therapeutic options.

Key Points:

Therapy developers are forging partnerships with technology providers, such as CellFE, to advance innovative solutions, with the aim to benefit patients seeking better therapeutic options.
CellFE's innovative, non-viral, microfluidic cell engineering platform, Infinity MTx™ system, performs complex genetic cell editing through streamlined, advanced workflows.
"Our vision of advancing the platform to a decentralized and point of care application will expand access to cell therapies for millions of patients."
CellFE presents a unique technology platform addressing key industry pain points across viral, but also other non-viral methods," said Christian Uhrich, Principal at M Ventures.